PrimeRFP SCOUT · Federal Contract Recompete Brief

HHSO100201600009C — DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT)

DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT) is a federal NONE award for Department of Health and Human Services (HHS) held by CERUS CORPORATION. Estimated value $197.8M ($68.2M obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder.

$197.8M
Estimated Value
$68.2M
Obligated
Sep 30, 2026
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

CERUS CORPORATION holds $37.0M across 28 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract numberHHSO100201600009C
AgencyDepartment of Health and Human Services (HHS)
IncumbentCERUS CORPORATION
UEIKJJQRRLY2FL5
NAICS541711

No full NAICS 541711 intel page yet. Browse NAICS intelligence

PSCAN13
PoP end (current)Sep 30, 2026
Obligated$68.2M

DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT)

Recompete timing

Public
Expiring in 44 days

Current PoP ends Sep 30, 2026 (44 days remaining). Agencies typically plan 12–18 months ahead — at 1.4 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

CERUS CORPORATION$37.0M obligated across 28 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($37.0M) · all agencies
Department of Health and Human Services (HHS)$35.8M · 97%Department of Defense (DOD)$1.3M · 4%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for HHSO100201600009C
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open CERUS CORPORATION’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract HHSO100201600009C?

HHSO100201600009C (DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT)) is a Department of Health and Human Services (HHS) award with an estimated value of $197.8M, currently held by CERUS CORPORATION. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on HHSO100201600009C?

CERUS CORPORATION is the incumbent with $37.0M across 28 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does HHSO100201600009C come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HHSO100201600009C